BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7835588)

  • 1. Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection.
    Durazzo M; Philipp T; Van Pelt FN; Lüttig B; Borghesio E; Michel G; Schmidt E; Loges S; Rizzetto M; Manns MP
    Gastroenterology; 1995 Feb; 108(2):455-62. PubMed ID: 7835588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heterogeneity of antimicrosomal autoantibodies in chronic hepatitis C virus infection and delta hepatitis].
    Durazzo M; Costa C; Schmidt E; Loges S; Scaglione L; Touscoz AG; Smedile A; Manns MP; Rizzetto M; Pagano G
    Ann Ital Med Int; 1995; 10(2):93-7. PubMed ID: 7542466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis.
    Strassburg CP; Obermayer-Straub P; Alex B; Durazzo M; Rizzetto M; Tukey RH; Manns MP
    Gastroenterology; 1996 Dec; 111(6):1576-86. PubMed ID: 8942737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.
    Philipp T; Durazzo M; Trautwein C; Alex B; Straub P; Lamb JG; Johnson EF; Tukey RH; Manns MP
    Lancet; 1994 Aug; 344(8922):578-81. PubMed ID: 7914961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
    Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
    Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
    Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-GOR in hepatitis D: specific association with hepatitis C virus superinfection.
    Durazzo M; Michel G; Philipp T; Braun HB; Luttig B; Rizzetto M; Manns M
    Int J Clin Lab Res; 1994; 24(4):227-9. PubMed ID: 7894050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
    Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
    J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
    Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
    Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral induction of autoimmunity: mechanisms and examples in hepatology.
    Manns MP; Obermayer-Straub P
    J Viral Hepat; 1997; 4 Suppl 2():42-7. PubMed ID: 9429209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
    Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
    Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
    Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
    J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.
    Lindgren S; Braun HB; Michel G; Nemeth A; Nilsson S; Thome-Kromer B; Eriksson S
    Scand J Gastroenterol; 1997 Feb; 32(2):175-8. PubMed ID: 9051879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
    Klein R; Zanger UM; Berg T; Hopf U; Berg PA
    Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
    Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
    Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sera of children with hepatitis C infection and anti-liver-kidney microsome-1 antibodies recognize different CYP2D6 epitopes than adults with LKM+/HCV+ sera.
    Herzog D; Yamamoto AM; Jara P; Maggiore G; Sarles J; Alvarez F
    J Pediatr Gastroenterol Nutr; 1999 Nov; 29(5):551-5. PubMed ID: 10554122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
    Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
    Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of autoantigens in hepatitis D.
    Philipp T; Straub P; Durazzo M; Tukey RH; Manns MP
    J Hepatol; 1995; 22(1 Suppl):132-5. PubMed ID: 7602065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
    Komurasaki R; Imaoka S; Tada N; Okada K; Nishiguchi S; Funae Y
    Drug Metab Pharmacokinet; 2010; 25(1):84-92. PubMed ID: 20208391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.